Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune-related Colitis”

35 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 35 results

Not applicableStudy completedNCT06074874
What this trial is testing

Intestinal Biomarker Analysis After ECP for ICI Colitis

Who this might be right for
ColitisImmune Checkpoint Inhibitor-Related Colitis
University of Freiburg 20
Testing effectiveness (Phase 2)WithdrawnNCT06521762
What this trial is testing

Etrasimod for Immune Checkpoint Inhibitor Diarrhea and Colitis

Who this might be right for
Immune Checkpoint Inhibitor-Related Diarrhea and Colitis
Yale University
Testing effectiveness (Phase 2)Active Not RecruitingNCT04407247
What this trial is testing

Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma

Who this might be right for
ColitisLung Non-Small Cell CarcinomaMalignant Genitourinary System Neoplasm+2 more
M.D. Anderson Cancer Center 47
Testing effectiveness (Phase 2)Looking for participantsNCT05726396
What this trial is testing

A Pilot Study Testing the Safety and Feasibility of Restorative Microbiota Therapy (RMT) in Patients With Refractory Immune-checkpoint Inhibitor-related Colitis

Who this might be right for
Immune-related ColitisColitis
University of Minnesota 20
Not applicableStudy completedNCT05414552
What this trial is testing

ECP for Immune-related Adverse Events After Checkpoint Inhibitor Treatment

Who this might be right for
Immune Related Adverse EventsColitisHepatitis+1 more
University of Freiburg 11
Early research (Phase 1)Study completedNCT06291948
What this trial is testing

A Clinical Study With Adalimumab Biosimilar

Who this might be right for
PharmacokineticsSafety Issues
Laboratorios Richmond S.A.C.I.F. 150
Not applicableLooking for participantsNCT06862843
What this trial is testing

Study on Eating Habits and Association with "omic" Profiles in Families with a Subject Affected by a Chronic Immune-mediated Inflammatory Pathology. Observational Multicenter Study.

Who this might be right for
Juvenile Idiopathic Arthritis (JIA)Crohn Disease (CD)Ulcerative Colitis (UC)
Meyer Children's Hospital IRCCS 90
Testing effectiveness (Phase 2)WithdrawnNCT06646016
What this trial is testing

EPIC- Extracorporeal Photopheresis (ECP) for Immune-related Colitis

Who this might be right for
Immune-related Colitis
Therakos LLC
Testing effectiveness (Phase 2)Active Not RecruitingNCT04305145
What this trial is testing

Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis

Who this might be right for
Melanoma Stage IIIMelanoma Stage IVSkin Cancer Stage III+4 more
Massachusetts General Hospital 42
Not applicableStudy completedNCT02750800
What this trial is testing

Post-marketing Observational Study to Evaluate the Incremental Impact of AbbVie's Patient Support Program on Patient Reported Outcomes and Health Resource Utilization in Inflammatory Arthritis, Psoriasis and Inflammatory Bowel Diseases in Hungary (VALUE)

Who this might be right for
Rheumatoid ArthritisAnkylosing SpondylitisPsoriatic Arthritis+3 more
AbbVie 427
Not applicableStudy completedNCT00002273
What this trial is testing

Ganciclovir in the Treatment of Cytomegalovirus of the Large Intestine in Patients With AIDS

Who this might be right for
ColitisHIV Infections
Hoffmann-La Roche
Not applicableUnknownNCT05635266
What this trial is testing

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

Who this might be right for
Age-Related Macular DegenerationAllergiesAlpha-Gal Syndrome+44 more
Sanguine Biosciences 20,000
Early research (Phase 1)Looking for participantsNCT07196410
What this trial is testing

KAN-004 for Immune-Related Diarrhea or Colitis

Who this might be right for
ColitisDiarrhea Caused by Antitumor Drugs
Centre hospitalier de l'Université de Montréal (CHUM) 21
Testing effectiveness (Phase 2)Looking for participantsNCT06841705
What this trial is testing

Early Vedolizumab as First-Line for Immune-Related Colitis Therapy Trial

Who this might be right for
Immune Checkpoint Inhibitor-Related Colitis
Shilpa Grover, MD, MPH 80
Not applicableWithdrawnNCT01709201
What this trial is testing

Reducing Problematic Substance Use in Youth With Chronic Medical Conditions

Who this might be right for
Alcohol AbuseDrug Abuse
Boston Children's Hospital
Not applicableLooking for participantsNCT00001184
What this trial is testing

Immune Regulation in Ulcerative Colitis or Crohn s Disease

Who this might be right for
Inflammatory Bowel DiseaseUlcerative ColitisChrohn's Disease
National Institute of Allergy and Infectious Diseases (NIAID) 1,000
Not applicableStudy completedNCT05584735
What this trial is testing

Determining the Relationship Between Gut Microbiota and Immune Response to Influenza or COVID-19 Vaccine

Who this might be right for
Inflammatory Bowel Diseases
University of Wisconsin, Madison 46
Large-scale testing (Phase 3)Looking for participantsNCT06337695
What this trial is testing

Vedolizumab for the Prevention of ICI Related Diarrhea or Colitis in Patients With Cancer

Who this might be right for
IrAEImmune-related Adverse EventDiarrhea+1 more
AHS Cancer Control Alberta 36
Not applicableStudy completedNCT01931644
What this trial is testing

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

Who this might be right for
All Diagnosed Health ConditionsADD/ADHDAlopecia Areata+58 more
Sanguine Biosciences 17,667
Not applicableStudy completedNCT01476995
What this trial is testing

Prognostic Indicators as Provided by the EPIC ClearView

Who this might be right for
Coronary Artery DiseaseCongestive Heart FailureValvular Heart Disease+25 more
Epic Research & Diagnostics, Inc. 353
Next Page